GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stimcell Energetics Inc (OTCPK:STME) » Definitions » Debt-to-Equity

STME (Stimcell Energetics) Debt-to-Equity : -0.35 (As of Feb. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Stimcell Energetics Debt-to-Equity?

Stimcell Energetics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2025 was $0.00 Mil. Stimcell Energetics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2025 was $0.38 Mil. Stimcell Energetics's Total Stockholders Equity for the quarter that ended in Feb. 2025 was $-1.07 Mil. Stimcell Energetics's debt to equity for the quarter that ended in Feb. 2025 was -0.35.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Stimcell Energetics's Debt-to-Equity or its related term are showing as below:

STME' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.68   Med: -0.35   Max: -0.11
Current: -0.35

During the past 13 years, the highest Debt-to-Equity Ratio of Stimcell Energetics was -0.11. The lowest was -0.68. And the median was -0.35.

STME's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.21 vs STME: -0.35

Stimcell Energetics Debt-to-Equity Historical Data

The historical data trend for Stimcell Energetics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stimcell Energetics Debt-to-Equity Chart

Stimcell Energetics Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.33 -0.19 -0.31 -0.42 -0.38

Stimcell Energetics Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.45 -0.38 -0.35 -0.36 -0.35

Competitive Comparison of Stimcell Energetics's Debt-to-Equity

For the Medical Devices subindustry, Stimcell Energetics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stimcell Energetics's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stimcell Energetics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Stimcell Energetics's Debt-to-Equity falls into.


;
;

Stimcell Energetics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Stimcell Energetics's Debt to Equity Ratio for the fiscal year that ended in May. 2024 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.313 + 0) / -0.826
=-0.38

Stimcell Energetics's Debt to Equity Ratio for the quarter that ended in Feb. 2025 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0.378) / -1.07
=-0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stimcell Energetics  (OTCPK:STME) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Stimcell Energetics Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Stimcell Energetics's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Stimcell Energetics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stimcell Energetics Inc (OTCPK:STME) » Definitions » Debt-to-Equity
Comparable Companies
MOVE VYCO IRME AMIX RSLS VERO HSCS NUMD ADMT TIVC ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
1130 Pender Street, West, Suite 820, Vancouver, BC, CAN, V6E 4A4
Website
https://www.stimcell.com
Stimcell Energetics Inc is a biotech company focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness and alleviate health complications including, but not limited to: aging, diabetes, high blood pressure, neuropathy and kidney function. The Company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System.
Executives
Richard Jeffs 10 percent owner FLAT 7, 6 ENNISMORE GARDENS, LONDON X0 SW7 1NL
Dwayne Yaretz director, officer: Chief Executive Officer SUITE 1050 WEST PENDER STREET SUITE 2250, VANCOUVER A1 V6E 3S7
Bradley S Hargreaves 10 percent owner 904-1616 BAYSHORE DR, VANCOUVER A1 V6G3L1
Frank Mcenulty director, officer: CEO, CFO, Treas., Sec 4182 N. VIKING WAY, SUITE 216, LONG BEACH CA 90808-1475
Joao Dacosta director, officer: COO #810 - 789 WEST PENDER STREET, VANCOUVER A1 V6C 1H2
George Adams director 7535 CONSERVATION ROAD, GUELPH A6 N1H6J1
Terrance George Owen director, officer: CEO 635 FOURTH LINE (UNIT 1), OAKVILLE A6 L6L 5BO
John David Sanderson officer: Chief Medical Officer 9 ISLANDVIEW, IRVINE CA 92604
Yanika S Silina officer: CFO, Treasurer and Secretary 789 WEST PENDER STREET, UNIT 810, VANCOUVER A1 V6C 1H2
Jean M Arnett 10 percent owner 121 - 3989 HENNING DRIVE, BURNABY A1 V5C 6P8
Ean Kremer director, officer: Chief Technology Officer C/O PLANDEL RESOURCES, INC., 4575 DEAN MARTIN DRIVE, STE. 2206, LAS VEGAS NV 89103